1
|
Silva JVJ, Ludwig-Begall LF, Oliveira-Filho EFD, Oliveira RAS, Durães-Carvalho R, Lopes TRR, Silva DEA, Gil LHVG. A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control. Acta Trop 2018; 188:213-224. [PMID: 30195666 PMCID: PMC7092809 DOI: 10.1016/j.actatropica.2018.09.003] [Citation(s) in RCA: 62] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2018] [Revised: 09/02/2018] [Accepted: 09/03/2018] [Indexed: 02/07/2023]
Abstract
Chikungunya fever is a mosquito-borne viral illness characterized by a sudden onset of fever associated with joint pains. It was first described in the 1950s during a Chikungunya virus (CHIKV) outbreak in southern Tanzania and has since (re-) emerged and spread to several other geographical areas, reaching large populations and causing massive epidemics. In recent years, CHIKV has gained considerable attention due to its quick spread to the Caribbean and then in the Americas, with many cases reported between 2014 and 2017. CHIKV has further garnered attention due to the clinical diagnostic difficulties when Zika (ZIKV) and dengue (DENV) viruses are simultaneously present. In this review, topical CHIKV-related issues, such as epidemiology and transmission, are examined. The different manifestations of infection (acute, chronic and atypical) are described and a particular focus is placed upon the diagnostic handling in the case of ZIKV and DENV co-circulating. Natural and synthetic compounds under evaluation for treatment of chikungunya disease, including drugs already licensed for other purposes, are also discussed. Finally, previous and current vaccine strategies, as well as the control of the CHIKV transmission through an integrated vector management, are reviewed in some detail.
Collapse
Affiliation(s)
- José V J Silva
- Oswaldo Cruz Foundation, Aggeu Magalhães Institute, Department of Virology, Recife, PE, Brazil; Federal University of Santa Maria, Department of Preventive Veterinary Medicine, Virology Section, Santa Maria, RS, Brazil.
| | - Louisa F Ludwig-Begall
- Liège University, Faculty of Veterinary Medicine, Department of Infectious and Parasitic Diseases, Belgium
| | | | - Renato A S Oliveira
- Federal University of Paraíba, Department of Fisiology and Pathology, João Pessoa, PB, Brazil
| | - Ricardo Durães-Carvalho
- Oswaldo Cruz Foundation, Aggeu Magalhães Institute, Department of Virology, Recife, PE, Brazil
| | - Thaísa R R Lopes
- Federal University of Pernambuco, Laboratory of Immunopathology Keizo Asami, Virology Section, Recife, PE, Brazil
| | - Daisy E A Silva
- Oswaldo Cruz Foundation, Aggeu Magalhães Institute, Department of Virology, Recife, PE, Brazil
| | - Laura H V G Gil
- Oswaldo Cruz Foundation, Aggeu Magalhães Institute, Department of Virology, Recife, PE, Brazil.
| |
Collapse
|
2
|
Silva JVJ, Arenhart S, Santos HF, Almeida-Queiroz SR, Silva ANMR, Trevisol IM, Bertani GR, Gil LHVG. Efficient assembly of full-length infectious clone of Brazilian IBDV isolate by homologous recombination in yeast. Braz J Microbiol 2015; 45:1555-63. [PMID: 25763067 PMCID: PMC4323336 DOI: 10.1590/s1517-83822014000400054] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2013] [Accepted: 04/17/2014] [Indexed: 12/03/2022] Open
Abstract
The Infectious Bursal Disease Virus (IBDV) causes immunosuppression in young chickens. Advances in molecular virology and vaccines for IBDV have been achieved by viral reverse genetics (VRG). VRG for IBDV has undergone changes over time, however all strategies used to generate particles of IBDV involves multiple rounds of amplification and need of in vitro ligation and restriction sites. The aim of this research was to build the world’s first VRG for IBDV by yeast-based homologous recombination; a more efficient, robust and simple process than cloning by in vitro ligation. The wild type IBDV (Wt-IBDV-Br) was isolated in Brazil and had its genome cloned in pJG-CMV-HDR vector by yeast-based homologous recombination. The clones were transfected into chicken embryo fibroblasts and the recovered virus (IC-IBDV-Br) showed genetic stability and similar phenotype to Wt-IBDV-Br, which were observed by nucleotide sequence, focus size/morphology and replication kinetics, respectively. Thus, IBDV reverse genetics by yeast-based homologous recombination provides tools to IBDV understanding and vaccines/viral vectors development.
Collapse
Affiliation(s)
- J V J Silva
- Departamento de Virologia e Terapia Experimental Centro de Pesquisas Aggeu Magalhães Fundação Oswaldo Cruz RecifePE Brazil Departamento de Virologia e Terapia Experimental, Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, PE, Brazil
| | - S Arenhart
- Departamento de Virologia e Terapia Experimental Centro de Pesquisas Aggeu Magalhães Fundação Oswaldo Cruz RecifePE Brazil Departamento de Virologia e Terapia Experimental, Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, PE, Brazil. ; Setor de Virologia, Departamento de Medicina Veterinária Preventiva Centro de Ciências Rurais Universidade Federal de Santa Maria Santa MariaRS Brazil Setor de Virologia, Departamento de Medicina Veterinária Preventiva, Centro de Ciências Rurais, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil
| | - H F Santos
- Laboratório de Virologia, Departamento de Microbiologia Imunologia e Parasitologia, Instituto de Ciências Básicas da Saúde Universidade Federal do Rio Grande do Sul Porto AlegreRS Brazil Laboratório de Virologia, Departamento de Microbiologia, Imunologia e Parasitologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - S R Almeida-Queiroz
- Departamento de Virologia e Terapia Experimental Centro de Pesquisas Aggeu Magalhães Fundação Oswaldo Cruz RecifePE Brazil Departamento de Virologia e Terapia Experimental, Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, PE, Brazil
| | - A N M R Silva
- Departamento de Virologia e Terapia Experimental Centro de Pesquisas Aggeu Magalhães Fundação Oswaldo Cruz RecifePE Brazil Departamento de Virologia e Terapia Experimental, Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, PE, Brazil
| | - I M Trevisol
- Embrapa Suínos e Aves ConcórdiaSC Brazil Embrapa Suínos e Aves, Concórdia, SC, Brazil
| | - G R Bertani
- Departamento de Bioquímica e Laboratório de Imunopatologia Keiso Asami Universidade Federal de Pernambuco RecifePE Brazil Departamento de Bioquímica e Laboratório de Imunopatologia Keiso Asami, Universidade Federal de Pernambuco, Recife, PE, Brazil
| | - L H V G Gil
- Departamento de Virologia e Terapia Experimental Centro de Pesquisas Aggeu Magalhães Fundação Oswaldo Cruz RecifePE Brazil Departamento de Virologia e Terapia Experimental, Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, PE, Brazil
| |
Collapse
|